FDA Adverse Event Malfunction Summary report: N

ALINITY I HBSAG REAGENT KIT

MDR report key: 21076030 · Received January 5, 2025

Report

Report Number
3008344661-2025-00001
Event Type
Malfunction
Date Received
January 5, 2025
Date of Event
December 9, 2024
Report Date
January 23, 2025
Manufacturer
ABBOTT IRELAND DIAGNOSTICS DIVISION
Product Code
LOM
UDI-DI
00380740130206
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ID
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AFTER FURTHER EVALUATION, THE SUSPECT MEDICAL DEVICE WAS CHANGED FROM ALINITY I HBSAG REAGENT KIT, LIST NUMBER 08P08-52, ABBOTT IRELAND DIAGNOSTICS DIVISION, SLIGO TO ALINITY I HBSAG QUALITATIVE II REAGENT KIT, LIST NUMBER 08P10-22, ABBOTT IRELAND DIAGNOSTICS DIVISION, SLIGO. MDR NUMBER 3008344661-2025-00010 HAS BEEN SUBMITTED AND ALL FURTHER INFORMATION WILL BE DOCUMENTED UNDER THAT MDR NUMBER.

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 8P08 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 4P53, WITH 510K/PMA/BLA NUMBER P110029. AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED A FALSE REACTIVE ALINITY I HBSAG FOR ONE PATIENT. THE CUSTOMER REPORTED THAT THE CURRENT RESULT WAS NOT CONSISTENT WITH THE HISTORICAL RESULT. THE RESULT IN 2023 WAS CONFIRMED WITH THE NEUTRALIZING CONFIRMATORY ASSAY AND THE RESULT IN 2024 WAS NOT CONFIRMED WITH THE NEUTRALIZING CONFIRMATORY ASSAY. THE 2024 SAMPLE ALSO WAS NON-REACTIVE FOR ANTI-HBS AND ANTI-HBC. THERE WERE NO SPECIFIC PATIENT RESULTS PROVIDED. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Description of Event or Problem · 0

THE CUSTOMER OBSERVED A FALSE REACTIVE ALINITY I HBSAG FOR ONE PATIENT. THE CUSTOMER REPORTED THAT THE CURRENT RESULT WAS NOT CONSISTENT WITH THE HISTORICAL RESULT. THE RESULT IN 2023 WAS CONFIRMED WITH THE NEUTRALIZING CONFIRMATORY ASSAY AND THE RESULT IN 2024 WAS NOT CONFIRMED WITH THE NEUTRALIZING CONFIRMATORY ASSAY. THE 2024 SAMPLE ALSO WAS NON-REACTIVE FOR ANTI-HBS AND ANTI-HBC. THERE WERE NO SPECIFIC PATIENT RESULTS PROVIDED. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
351118 ALINITY I HBSAG REAGENT KIT TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) LOM ABBOTT IRELAND DIAGNOSTICS DIVISION 00380740130206

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ALNTY I HBS AG QUAL CON, 08P11-22, UNKNOWN| ALNTY I HBS AG QUAL CON, 08P11-22, UNKNOWN| ALNTY I PROCESSING MODU, 03R65-01, AI24007| ALNTY I PROCESSING MODU, 03R65-01, AI24007